Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Phase I results reported for Cortecs' oral insulin

July 7, 1997

Proteoglycan synthesis increased by rhBMP-2

July 7, 1997

SmithKline Beecham and Nycomed disclose hemoregulatory compounds

July 7, 1997

Pharmacia & Upjohn discloses agents for diabetes

July 7, 1997

Low serum cholesterol levels increase risk of suicide in certain psychiatric disorders

July 4, 1997

Icos PDE V inhibitor in phase I trials

July 4, 1997

Exocell presents new small-molecule antiglycation agent

July 4, 1997

Rebamipide for diabetic nephropathy

July 3, 1997

Edex cleared for erectile dysfunction in the U.S.

July 2, 1997

Injectable microsphere-encapsulated norethindrone is a safe and effective contraceptive

July 2, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 26, 2026.
Sangamo presents primate data for prion suppressor ST-506
BioWorld Science
Sangamo Therapeutics Inc. discussed gene regulation approaches for neurodegenerative diseases when presenting findings on their clinical candidate ST-506 for the...
TREM2 agonists detailed in Pfizer patent
BioWorld Science
Pfizer Inc. has reported new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for the treatment of neurodegeneration.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
Dual-targeting, rapamycin-enhanced CAR T for multiple myeloma
BioWorld Science
Umoja Biopharma Inc. performed preclinical studies to evaluate the antitumor activity of UB-VV500, an off-the-shell lentiviral vector CAR T-cell product. It is...